JACQUELINE ERBSE: Open Payments
NPI 1790169142 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,119 in 94 payments from 20 companies in 2025. Trend: 2023 $3,220 · 2024 $3,548 · 2025 $2,119
Food & beverage: $2,119
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $342 |
| Phathom Pharmaceuticals, Inc. | 13 | $277 |
| Janssen Biotech, Inc. | 6 | $231 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $215 |
| Ardelyx, Inc. | 9 | $204 |
| Novo Nordisk Inc | 2 | $149 |
| Lilly USA, LLC | 4 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $95 |
| Janssen Scientific Affairs, LLC | 1 | $75 |
| Madrigal Pharmaceuticals | 3 | $67 |
Products named: TREMFYA, VOQUEZNA, XIFAXAN, IBSRELA, Wegovy, RINVOQ, OMVOH, CREON.
Industry payments across KY — which companies pay providers there.
